| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 83.80 / 84.98 |
Medicines Company (MDCO)
0.00
NASDAQ
| Exchange | NASDAQ |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not
We're seeing lots of companies snapping up their peers, and the market is applauding.
Positive Developments for These 3 Biotech Stocks
We review Acadia Pharmaceuticals, The Medicines Company, and Flexion Therapeutics.
These 5 Small Caps Are Well Positioned Despite Escalating Trade Tensions
They're the kind of names, along with a big dollop of cash in my portfolio, I plan to wait out the 'trade wars'.
These 2 Stocks Are on the Move
After an initial burst upward to start trading on Monday, indices have slowly pulled back from their highest levels of the day. Shipping stocks are having a good day on the resumption of trade talks between the U.S. and China. The stock of Hooker Fu...
These 3 Biotech Stocks Are Attracting Insider Buying
What are insiders buying as the market sells off in recent trading sessions?
Insider Buying Is Still Alive and Well at These 3 Companies
Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.
Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019
From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.
Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers
The New Haven, Conn.-based firm on Nov. 29 unveiled a deal to acquire The Medicines Co.'s infectious disease unit.
MacroGenics Soars on Collaboration with Incyte -- Biotech Movers
MacroGenics and Incyte on Wednesday unveiled a collaboration and license agreement regarding MGA012, MacroGenics' investigational monoclonal antibody that inhibits programmed cell death protein 1.
The Medicines Group Rises, More Gains Coming
Market maintaining momentum and Dow right at the 20,000 milestone as we have one hour left in a very encouraging opening week in the market, provided you are not in department store names this week. Neiman Marcus pulls its IPO, with the news from Ma...
Prepare for Biotech Action Aplenty Today
As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages. Amgen should be up nicely today after a judge stated that Regeneron would have to pull its PCKS9 inh...
Market Wrap: Manic Month Ends With a Loss
Energy stocks rally as price of oil climbs.
Morning Market Look
Let's take a look at the overnight and early-morning price action in the major asset classes. This is dedicated to our dysfunctional leaders in Washington, D.C. : We met at a party last week And the moment your eyes looked into mine Right then I ju...
Pulling for a Pullback
It's the close that counts.